Abstract:BACKGROUND Sepsis, which is characterized by acute systemic inflammation and is associated with high rates of morbidity and mortality, presents a significant challenge in health care. Some scholars have found that the sequential organ failure assessment (SOFA) and quick SOFA scores are not ideal for predicting severe sepsis and mortality. Microbial culture takes a long time (2-3 d) and provides no information for early diagnosis and treatment. Therefore, new diagnostic methods for sepsis need to be explored. AIM To assess cytokine levels in the plasma of sepsis patients and identify potential biomarkers for diagnosing sepsis. METHODS Ten sepsis patients admitted to the emergency department within 24 h of onset were enrolled as the observation group, whereas ten noninfected patients served as the control group. Of the 10 noninfected patients, 9 hypertension combined with cerebral infarction, 1 patients with vertiginous syndrome. Plasma Cytokines were measured using the Bio-Plex ProTM Human Chemokine Panel 40-plex. Differentially expressed cytokines in plasma of sepsis and nonsepsis patients were analyzed using Gene Ontology (GO) functional enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses. RESULTS Interleukin (IL)-16, granulocyte-macrophage granulocyte-macrophage colony-stimulating factor (GM-CSF), CX3CL1, CXCL9, CXCL16, CCL25, and CCL23 plasma levels were significantly increased in sepsis patients. GO analysis revealed that these cytokines were mainly associated with cellular structures such as intermediates, nuclear plaques, adhesion plaques, lateral plasma membranes, and cell matrix junctions. These genes were involved in various molecular functions, such as cytokine activity, receptor ligand activity, and signal receptor activator activity, contributing to various biological functions, such as leukocyte chemotaxis, migration, and chemotaxis. KEGG analysis indicated involvement in cytokine cytokine receptor interactions, chemokine signaling pathways, virus–protein interactions with cytokines and cytokine receptors, and the tumor necrosis factor signaling pathway. CONCLUSION Elevated serum levels of IL-16, GM-CSF, CX3CL1, CXCL9, CXCL16, CCL25, and CCL23 in sepsis patients suggest their potential as diagnostic biomarkers for sepsis.

Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis.

Biology of Interleukin-17 and Its Pathophysiological Significance in Sepsis

Effect of Interleukin-36β on Activating Autophagy of CD4+CD25+ Regulatory T Cells and Its Immune Regulation in Sepsis.

Immunomodulation of Interleukin-34 and Its Potential Significance As a Disease Biomarker and Therapeutic Target

Interleukin-38 protects against sepsis by augmenting immunosuppressive activity of CD4+ CD25+ regulatory T cells.

Biological functions and clinical implications of interleukin-34 in inflammatory diseases

Interleukin‐38 protects against sepsis by augmenting immunosuppressive activity of CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells

[Research advance on the role of pro-inflammatory cytokines in sepsis].

The growing spectrum of anti-inflammatory interleukins and their potential roles in the development of sepsis.

Protective Role of Ilc2 in Sepsis-Induced Acute Lung Injury

Differential expression of plasma cytokines in sepsis patients and their clinical implications

[Research advances of inflammasome and its role in sepsis].

IL-33 Attenuates Sepsis by Inhibiting IL-17 Receptor Signaling through Upregulation of SOCS3.

Interleukin 35 contributes to immunosuppression by regulating inflammatory cytokines and T cell populations in the acute phase of sepsis

The significance and regulatory mechanisms of innate immune cells in the development of sepsis.

Research advances on the regulation of interleukin-17 signal transduction and the implication of interleukin-17 in sepsis

Single-cell transcriptional gene signature analysis identifies IL-17 signaling pathway as the key pathway in sepsis

Alterations in levels of cytokine following treatment to predict outcome of sepsis: A meta-analysis

Identification of key biomarkers and therapeutic targets in sepsis through coagulation-related gene expression and immune pathway analysis

Progress on biomarkers of sepsis

Novel therapeutic targets for sepsis: regulation of exaggerated inflammatory responses.